Lithium suppresses Aβ pathology by inhibiting translation in an adult Drosophila model of Alzheimer's disease

Frontiers in Aging Neuroscience

Volumn 6, Issue JUL, 2014, Pages

  Sofola Adesakin, Oyinkan ^a,b   Castillo Quan, Jorge Iván ^a,b   Rallis, Charalampos ^a   Tain, Luke ^b   Bjedov, Ivana ^a,c   Rogers, Iain ^a   Li, Li ^a   Martinez, Pedro ^a,b   Khericha, Mobina ^a,b   Cabecinha, Melissa ^a   Bähler, Jürg ^a   Partridge, Linda ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MAX PLANCK INSTITUTE FOR BIOLOGY OF AGEING   (Germany)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; GREEN FLUORESCENT PROTEIN; LITHIUM; MAMMALIAN TARGET OF RAPAMYCIN;

ADULT; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; FRUIT FLY MODEL; LIFE EXPECTANCY; LIFE EXTENSION; LIFESPAN; MORTALITY; NERVE CELL NECROSIS; NONHUMAN; PATHOGENESIS; POLYSOME; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN HOMEOSTASIS; PROTEIN PROCESSING; PROTEIN SYNTHESIS; SCHIZOSACCHAROMYCES; SCHIZOSACCHAROMYCES POMBE; TRANSLATION INITIATION;

EID: 84904635241     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00190     Document Type: Article

References (52)

1. Alzheimer's Association (2012). 2012 Alzheimer's disease facts and figures. Alzheimer's Dement. 8, 131- 68.
2. Bjedov, I., and Partridge, L. (2011). A longer and healthier life with TOR down-regulation: genetics and drugs. Biochem. Soc. Trans. 39, 460-5.
3. Bjedov, I., Toivonen, J. M., Kerr, F., Slack, C., Jacobson, J., Foley, A., and Partridge, L. (2010). Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metab. 11, 35-46.
4. Bosetti, F., Seemann, R., and Rapoport, S. I. (2002). Chronic lithium chloride administration to rats decreases brain protein level of epsilon (epsilon) subunit of eukaryotic initiation factor-2B. Neurosci. Lett. 327, 71-3.
5. Browne, G. J., and Proud, C. G. (2002). Regulation of peptide-chain elongation in mammalian cells. Eur. J. Biochem. 269, 5360-5368.
6. Bulteau, A., Moreau, M., Nizard, C., and Friguet, B. (2002). Imapairment of Proteasome function upon UVA- and UVB- irradiation of human keratinocytes. Free Radic. Biol. Med. 32, 1157-1170.
7. Can, A., Blackwell, R. A., Piantadosi, S. C., Dao, D. T., O'Donnell, K. C., and Gould, T. D. (2011). Antidepressant-like responses to lithium in genetically diverse mouse strains. Genes. Brain. Behav. 10, 434-43.
8. Castillo-Quan, J. I. (2011). Parkin' control: regulation of PGC-1α through PARIS in Parkinson's disease. Dis. Model. Mech. 4, 427-29.
9. Chiu, C.-T., Liu, G., Leeds, P., and Chuang, D.-M. (2011). Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease. Neuropsychopharmacology 36, 2406-21.
10. Crowther, D. C., Kinghorn, K. J., Miranda, E., Page, R., Curry, J. A., Duthie, F. A. I., Gubb, D. C., and Lomas, D. A. (2005). Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease. Neuroscience 132, 123-35.
11. Dinkova, T. D., Keiper, B. D., Korneeva, N. L., Aamodt, E. J., and Rhoads, R. E. (2005). Translation of a Small Subset of Caenorhabditis elegans mRNAs Is Dependent on a Specific Eukaryotic Translation Initiation Factor 4E Isoform. Mol. Cell. Biol. 1, 100-113.
12. Dokucu, M. E., Yu, L., and Taghert, P. H. (2005). Lithium- and valproate-induced alterations in circadian locomotor behavior in Drosophila. Neuropsychopharmacology 30, 2216-24.
13. Forlenza, O. V, Torres, C. A., Talib, L. L., de Paula, V. J., Joaquim, H. P. G., Diniz, B. S., and Gattaz, W. F. (2011). Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease. J. Psychiatr. Res. 45, 220-4.
14. Hampel, H., Ewers, M., Bürger, K., Annas, P., Mörtberg, A., Bogstedt, A., Frölich, L., Schröder, J., Schönknecht, P., Riepe, M. W., et al. (2009). Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study. J. Clin. Psychiatry 70, 922-931.
15. Hansen, M., Taubert, S., Crawford, D., Libina, N., Lee, S.-J., and Kenyon, C. (2007). Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans. Aging Cell 6, 95-110.
16. Hipkiss, A. R. (2007). On why decreasing protein synthesis can increase lifespan. Mech. Ageing Dev. 128, 412-4.
17. Jing, P., Zhang, J.-Y., Ouyang, Q., Wu, J., and Zhang, X.-J. (2013). Lithium treatment induces proteasomal degradation of over-expressed acetylcholinesterase (AChE-S) and inhibit GSK3β. Chem. Biol. Interact. 203, 309-13.
18. De Jonghe, C., Esselens, C., Kumar-Singh, S., Craessaerts, K., Serneels, S., Checler, F., Annaert, W., Van Broeckhoven, C., and De Strooper, B. (2001). Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stability. Hum. Mol. Genet. 10, 1665-71.
19. Kaeberlein, M., Powers, R. W., Steffen, K. K., Westman, E. a, Hu, D., Dang, N., Kerr, E. O., Kirkland, K. T., Fields, S., and Kennedy, B. K. (2005). Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science (80-.). 310, 1193-6.
20. Karyo, R., Eskira, Y., Pinhasov, A., Belmaker, R., Agam, G., and Eldar-Finkelman, H. (2010). Identification of eukaryotic elongation factor-2 as a novel cellular target of lithium and glycogen synthase kinase-3. Mol. Cell. Neurosci. 45, 449-55.
21. Kasuya, J., Kaas, G., and Kitamoto, T. (2009). Effects of lithium chloride on the gene expression profiles in Drosophila heads. Neurosci. Res. 64, 413-20.
22. Kinghorn, K. J. (2011). Pathological looping in the synucleinopathies: investigating the link between Parkinson's disease and Gaucher disease. Dis. Model. Mech. 4, 713-5.
23. Ling, D., Song, H.-J., Garza, D., Neufeld, T. P., and Salvaterra, P. M. (2009). Abeta42-induced neurodegeneration via an age-dependent autophagic-lysosomal injury in Drosophila. PLoS One 4, e4201.
24. López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., and Kroemer, G. (2013). The Hallmarks of Aging. Cell 153, 1194-1217.
25. Macdonald, A., and Briggs, K. (2008). A feasibility and tolerability study of lithium in Alzheimer's disease. Int. J. Geriatr. Psychiatry 23, 704-711.
26. Machado-Vieira, R., Manji, H. K., and Zarate, C. a (2009). The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord. 11 Suppl 2, 92-109.
27. McColl, G., Killilea, D. W., Hubbard, A. E., Vantipalli, M. C., Melov, S., and Lithgow, G. J. (2008). Pharmacogenetic analysis of lithium-induced delayed aging in Caenorhabditis elegans. J. Biol. Chem. 283, 350-7.
28. Nixon, R. A., and Yang, D.-S. (2011). Autophagy failure in Alzheimer's disease--locating the primary defect. Neurobiol. Dis. 43, 38-45.
29. Nunes, P. V, Forlenza, O. V, and Gattaz, W. F. (2007). Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder. Br. J. Psychiatry 190, 359-60.
30. Oeppen, J., and Vaupel, J. W. (2002). Demography. Broken Limits to Life Expectancy. Science (80-.). 296, 1029-1031.
31. Osterwalder, T., Yoon, K. S., White, B. H., and Keshishian, H. (2001). A conditional tissue-specific transgene expression system using inducible GAL4. Proc. Natl. Acad. Sci. U. S. A. 98, 12596-601.
32. Pearson, R. B., Dennis, P. B., Han, J. W., Williamson, N. A., Kozma, S. C., Wettenhall, R. E., and Thomas, G. (1995). The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. EMBO J. 14, 5279-87.
33. Phiel, C. J., Wilson, C. A., Lee, V. M., and Klein, P. S. (2003). GSK-3alpha regulates production of Alzheimer ' s disease amyloid-beta peptides. Nature 423, 435-439.
34. Pimenta de Castro, I., Costa, A. C., Lam, D., Tufi, R., Fedele, V., Moisoi, N., Dinsdale, D., Deas, E., Loh, S. H. Y., and Martins, L. M. (2012). Genetic analysis of mitochondrial protein misfolding in Drosophila melanogaster. Cell Death Differ. 19, 1308-16.
35. Proud, C. G. (2002). Regulation of mammalian translation factors by nutrients. Eur. J. Biochem. 269, 5338-5349.
36. Rallis, C., Codlin, S., and Bähler, J. (2013). TORC1 signaling inhibition by rapamycin and caffeine affect lifespan, global gene expression, and cell proliferation of fission yeast. Aging Cell, 1-11.
37. Rockenstein, E., Torrance, M., Adame, A., Mante, M., Bar-on, P., Rose, J. B., Crews, L., and Masliah, E. (2007). Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation. J. Neurosci. 27, 1981-91.
38. Rogers, I., Kerr, F., Martinez, P., Hardy, J., Lovestone, S., and Partridge, L. (2012). Ageing increases vulnerability to aβ42 toxicity in Drosophila. PLoS One 7, e40569. Rubinsztein, D. C., Mariño, G., and Kroemer, G. (2011). Autophagy and aging. Cell 146, 682-95.
39. Rybakowski, J. K. (2011). Lithium in neuropsychiatry: a 2010 update. World J. Biol. Psychiatry 12, 340-8.
40. Sarkar, S., Carroll, B., Buganim, Y., Maetzel, D., Ng, A. H. M., Cassady, J. P., Cohen, M. a, Chakraborty, S., Wang, H., Spooner, E., et al. (2013). Impaired autophagy in the lipid-storage disorder niemannpick type c1 disease. Cell Rep. 5, 1302-15.
41. Sarkar, S., Floto, R. A., Berger, Z., Imarisio, S., Cordenier, A., Pasco, M. M., Cook, L. J., and Rubinsztein, D. C. (2005). Lithium induces autophagy by inhibiting inositol monophosphatase. J. Cell Biol. 170, 1101-11.
42. Schou, M. (2001). Lithium treatment at 52. J. Affect. Disord. 67, 21-32.
43. Shin, S., Wolgamott, L., Tcherkezian, J., Vallabhapurapu, S., Yu, Y., Roux, P. P., and Yoon, S.-O. (2014). Glycogen synthase kinase-3β positively regulates protein synthesis and cell proliferation through the regulation of translation initiation factor 4E-binding protein 1. Oncogene 33, 1690-9.
44. Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003). alpha-Synuclein Locus Triplication Causes Parkinson's Disease. Science (80-.). 302, 2003.
45. Sofola, O., Kerr, F., Rogers, I., Killick, R., Augustin, H., Gandy, C., Allen, M. J., Hardy, J., Lovestone, S., and Partridge, L. (2010). Inhibition of GSK-3 Ameliorates Aβ Pathology in an Adult-Onset Drosophila Model of Alzheimer's Disease. PLoS Genet. 6, e1001087.
46. Spires, T., and Hyman, B. (2005). Transgenic Models of Alzheimer's Disease: Learning from Animals. NeuroRx 2, 423-437.
47. Theuns, J., Brouwers, N., Engelborghs, S., Sleegers, K., Bogaerts, V., Corsmit, E., De Pooter, T., van Duijn, C. M., De Deyn, P. P., and Van Broeckhoven, C. (2006). Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease. Am. J. Hum. Genet. 78, 936-46.
48. Whitworth, A., Wes, P., and Pallanck, L. (2006). Drosophila models pioneer a new approach to drug discovery for Parkinson's disease. Drug Discov. Today 11, 119-126.
49. Wiseman, F. K., Alford, K. a, Tybulewicz, V. L. J., and Fisher, E. M. C. (2009). Down syndrome--recent progress and future prospects. Hum. Mol. Genet. 18, R75-83.
50. Wong, E., and Cuervo, A. M. (2010). Autophagy gone awry in neurodegenerative diseases. Nat. Neurosci. 13, 805-11.
51. Wood, A., Goodwin, G., De Souza, R., and Green, A. (1986). The pharmcokinetic profile of lithium in rat and mouse; an important factor in psychopharmacological investigation of the drug. Neuropharmacology 25, 1285-1288.
52. Zarse, K., Terao, T., Tian, J., Iwata, N., Ishii, N., and Ristow, M. (2011). Low-dose lithium uptake promotes longevity in humans and metazoans. Eur. J. Nutr. 50, 387-9.